SCHEMBL6286756

SCHEMBL6286756

Cc1[nH]c2ccccc2c1CC(=O)NCCC(=O)Nc1ccc(C(c2ccc(NC(=O)CCNC(=O)Cc3c(C)[nH]c4ccccc34)cc2)c2ccc(NC(=O)CCNC(=O)Cc3c(C)[nH]c4ccccc34)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
GAA P10253 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
PABPC1 P11940 1/20 0.47
ALOX15 P16050 1/20 0.47
KLK6 Q92876 2/20 0.47
KMT2A Q03164 2/20 0.44
EGFR P00533 1/20 0.44
SRC P12931 1/20 0.44
HPGD P15428 2/20 0.43
KDM1A O60341 1/20 0.43
LMNA P02545 1/20 0.42
DNMT3B Q9UBC3 1/20 0.42
P2RY12 Q9H244 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287385 0.89 KDM4E (0.51) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6287883 0.84 AKR1C2 (0.54) ALDH1A1MAPTGAATDP1KMT2A
SCHEMBL6286761 0.81 KDM4E (0.49) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6287814 0.79 HDAC1 (0.50) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6287891 0.78 MAPT (0.54) ALDH1A1MAPTKMT2ALMNAMEN1
SCHEMBL6290839 0.78 HDAC1 (0.56) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6290828 0.78 CASP1 (0.51) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6287331 0.77 HDAC1 (0.53) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6290656 0.77 HDAC1 (0.48) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL6286718 0.77 HDAC1 (0.50) KDM4EALDH1A1MAPTGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK KDM4E 2972/4885ALDH1A1 2042/4885MAPT 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.